In model cancer cell types, overexpression of survivin was responsible for a cytoprotective effect, counteracting apoptosis induced by Fas/TNF-R (tumor necrosis factor receptor) engagement, pro-apoptotic proteins such as Bax, effector caspases, and several chemotherapeutic drugs [31] (Figure 2). Here, BIRC5 is linked to cancer.